TOLBUTAMIDE AS A MODEL-DRUG FOR THE STUDY OF ENZYME-INDUCTION AND ENZYME-INHIBITION IN THE RAT

被引:35
作者
BACK, DJ
SUTCLIFFE, F
TJIA, JF
机构
关键词
D O I
10.1111/j.1476-5381.1984.tb10109.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:557 / 562
页数:6
相关论文
共 28 条
[1]   PHENOBARBITONE INTERACTION WITH ORAL-CONTRACEPTIVE STEROIDS IN THE RABBIT AND RAT [J].
BACK, DJ ;
BRECKENRIDGE, AM ;
CRAWFORD, FE ;
ORME, ML ;
ROWE, PH .
BRITISH JOURNAL OF PHARMACOLOGY, 1980, 69 (03) :441-452
[2]   INHIBITION OF DRUG-METABOLISM BY THE ANTI-MALARIAL DRUGS CHLOROQUINE AND PRIMAQUINE IN THE RAT [J].
BACK, DJ ;
PURBA, HS ;
STAIGER, C ;
ORME, ML ;
BRECKENRIDGE, AM .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (02) :257-263
[3]   NORPHENAZONE, A NEW METABOLITE OF PHENAZONE IN HUMAN URINE [J].
BATY, JD ;
PRICEEVA.DA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (01) :83-84
[4]   COMPARISON OF THE INVIVO AND INVITRO RATES OF FORMATION OF THE 3 MAIN OXIDATIVE METABOLITES OF ANTIPYRINE IN MAN [J].
BOOBIS, AR ;
BRODIE, MJ ;
KAHN, GC ;
TOVERUD, EL ;
BLAIR, IA ;
MURRAY, S ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (06) :771-777
[5]  
BRODIE BB, 1950, J PHARMACOL EXP THER, V98, P97
[6]  
CHRISTENSEN LK, 1963, LANCET, V2, P1298
[7]   DIFFERENTIAL-EFFECTS OF ENZYME-INDUCTION ON ANTIPYRINE METABOLITE FORMATION [J].
DANHOF, M ;
VERBEEK, RMA ;
VANBOXTEL, CJ ;
BOEIJINGA, JK ;
BREIMER, DD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (03) :379-386
[8]   STUDIES ON THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN RATS - INFLUENCE OF PHENOBARBITAL AND 3-METHYLCHOLANTHRENE TREATMENT [J].
DANHOF, M ;
KROM, DP ;
BREIMER, DD .
XENOBIOTICA, 1979, 9 (11) :695-702
[9]   EFFECT OF CIMETIDINE ON ACETAMINOPHEN PHARMACOKINETICS IN RATS [J].
GALINSKY, RE ;
LEVY, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1982, 10 (04) :301-306
[10]   DRUG INTERACTIONS WITH ORAL SULFONYLUREA HYPOGLYCEMIC DRUGS [J].
HANSEN, JM ;
CHRISTENSEN, LK .
DRUGS, 1977, 13 (01) :24-34